Literature DB >> 26477846

Combined Persistent Fetal Vasculature: A Classification Based on High-Resolution B-Mode Ultrasound and Color Doppler Imaging.

Andina Hu1, Xiaoqing Pei2, Xiaoyan Ding1, Jiaqing Li1, Yonghao Li1, Fang Liu1, Zijing Li1, Zongyi Zhan1, Lin Lu3.   

Abstract

PURPOSE: The purpose of this study was to classify combined persistent fetal vasculature (PFV) on the basis of the ultrasonographic and Doppler characteristics. The potential clinical significance for both surgery design and prognosis determination was discussed.
DESIGN: A cross-sectional case series. PARTICIPANTS: The eyes of 54 children diagnosed with unilateral combined PFV were evaluated using B-mode ultrasound and color Doppler imaging (CDI).
METHODS: Each participant's age at first presentation, diagnosis for referral, gender, family history, and systemic or other ocular anomalies were recorded. Retinal detachment, optic nerve abnormalities, and macular dislocation were also recorded in detail according to the RetCam (Clarity Medical Systems, Pleasanton, CA), ultrasound, and Doppler findings. The PFV eyes were divided into 4 groups on the basis of the ultrasound and CDI findings. Intergroup analysis was performed. MAIN OUTCOME MEASURES: Overall and intergroup analyses of the demographic features of the children with PFV were performed. The axial length, depth of the anterior chamber, and lens thickness were compared between the affected eyes and the fellow healthy eyes among the 4 groups.
RESULTS: Some 22.2%, 18.5%, 33.3%, and 25.9% of the eyes were grouped into type I ("I" shape), II ("Y" shape), III (inverted "Y" shape), and IV ("X" shape) combined PFV, respectively. The age at first presentation for type I was older than that for the other groups (P = 0.014). The axial length was reduced (P = 0.012) and the anterior chamber more shallow (P = 0.011) than in fellow healthy eyes for type IV eyes, but not for the other 3 groups.
CONCLUSIONS: Ultrasound and CDI are informative screening and diagnostic tools that show characteristic flow patterns in the 4 types of combined PFV. This novel classification system provides new and important information for the diagnosis of PFV and, if validated, may play a role in guiding treatment recommendations in the future.
Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26477846     DOI: 10.1016/j.ophtha.2015.09.001

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Ocular development in children with unilateral congenital cataract and persistent fetal vasculature.

Authors:  Shu-Yi Zhang; Hui Chen; Jing-Hui Wang; Wan Chen; Qi-Wei Wang; Jing-Jing Chen; Xiao-Shan Lin; Zhuo-Ling Lin; Duo-Ru Lin; Hao-Tian Lin; Wei-Rong Chen
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

2.  Surgical outcomes of cataract surgery in anterior and combined persistent fetal vasculature using a novel surgical technique: a single center, prospective study.

Authors:  Surbhi Khurana; Jagat Ram; Ramandeep Singh; Parul Chawla Gupta; Rohit Gupta; Sonam Yangzes; Jaspreet Sukhija; Mangat Ram Dogra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-17       Impact factor: 3.117

3.  Persistent vasa hyaloidea propria/retinae in familial exudative vitreoretinopathy.

Authors:  Eric D Gaier; Yoshihiro Yonekawa
Journal:  J AAPOS       Date:  2020-12-21       Impact factor: 1.220

Review 4.  Innovations in pediatric cataract surgery.

Authors:  Sudarshan Kumar Khokhar; Ganesh Pillay; Esha Agarwal; Manish Mahabir
Journal:  Indian J Ophthalmol       Date:  2017-03       Impact factor: 1.848

Review 5.  Cataract management in children: a review of the literature and current practice across five large UK centres.

Authors:  J E Self; R Taylor; A L Solebo; S Biswas; M Parulekar; A Dev Borman; J Ashworth; R McClenaghan; J Abbott; E O'Flynn; D Hildebrand; I C Lloyd
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.